Dylan Morris
Managing Director·Insight Partners
Dylan Morris is a Managing Director at Insight Partners, where he leads the firm's bio practice. He joined Insight in 2021 to focus on investments at the intersection of computation and biology, including technology-enabled drug discovery, development, bioengineering and curative therapies. Public board bios list board roles at life sciences companies including Averna Therapeutics, Unlearn, Superluminal Medicines and Profluent.
See the rest of Dylan Morris's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.